Not applicableStudy completedNCT04135482What this trial is testingCD Patients Immune Status EvaluationWho this might be right forSevere Crohn's Diease First Affiliated Hospital of Zhejiang University 10
Not applicableActive Not RecruitingNCT05841537What this trial is testingAn Observational Study to Assess Change in Disease Activity and Adverse Events In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)Who this might be right forCrohn's Disease AbbVie 1,019
Not applicableStudy completedNCT04799496What this trial is testingKynteles Injection (Vedolizumab) in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease or Chronic PouchitisWho this might be right forInflammatory Bowel DiseasesColitis, UlcerativeCrohn Disease Takeda 688
Not applicableLooking for participantsNCT07385131What this trial is testingProphylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBDWho this might be right forInflammatory Bowel Disease (IBD)CD - Crohn's DiseaseUC - Ulcerative Colitis Second Affiliated Hospital, Zhejiang University, School of Medicine 300
Large-scale testing (Phase 3)Looking for participantsNCT07184944What this trial is testingA Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn's Disease Sanofi 751
Not applicableStudy completedNCT01218360What this trial is testingObservational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)Who this might be right forCrohn Disease Merck Sharp & Dohme LLC 71
Not applicableStudy completedNCT05192863What this trial is testingVedolizumab in Adults With Crohn's Disease (CD)Who this might be right forCrohn's Disease Takeda 72
Large-scale testing (Phase 3)Looking for participantsNCT07499232What this trial is testingGuselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn Disease Janssen Research & Development, LLC 530
Not applicableStudy completedNCT01428115What this trial is testingReveal the Level of Anxiety in Patients With Crohn's Disease Receiving AdalimumabWho this might be right forSevere Crohn's DiseaseAnxiety AbbVie (prior sponsor, Abbott) 83
Large-scale testing (Phase 3)Study completedNCT03283085What this trial is testingA Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)Who this might be right forCrohn's DiseaseUlcerative Colitis Shire 557
Testing effectiveness (Phase 2)Study completedNCT00306215What this trial is testingEvaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's Disease Amgen 436
Testing effectiveness (Phase 2)Study completedNCT02031276What this trial is testingEfficacy, Safety and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Patients With Active, Moderate-to-severe Crohn's Disease.Who this might be right forCrohn Disease AbbVie 121
Large-scale testing (Phase 3)Active Not RecruitingNCT05197049What this trial is testingGuselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn Disease Janssen Research & Development, LLC 350
Testing effectiveness (Phase 2)WithdrawnNCT01635621What this trial is testingA Phase II Study to Assess the Efficacy and Safety of Olokizumab in Patients With Crohn's DiseaseWho this might be right forCrohn's Disease UCB BIOSCIENCES GmbH
Testing effectiveness (Phase 2)Study completedNCT00615199What this trial is testingInvestigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's Disease Pfizer 139
Large-scale testing (Phase 3)Active Not RecruitingNCT04524611What this trial is testingStudy Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)Who this might be right forCrohn's Disease (CD) AbbVie 527
Large-scale testing (Phase 3)Active Not RecruitingNCT04738942What this trial is testingIntravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's DiseaseWho this might be right forUlcerative ColitisCrohn's Disease Takeda 56
Large-scale testing (Phase 3)Ended earlyNCT03440372What this trial is testingInduction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn Disease Celgene 625
Testing effectiveness (Phase 2)Looking for participantsNCT06548542What this trial is testingStudy of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's Disease AbbVie 590
Large-scale testing (Phase 3)Looking for participantsNCT06819878What this trial is testingAssess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's DiseaseWho this might be right forModerately to Severely Active Crohns Disease Hoffmann-La Roche 600